Healthcare

JNJ.N
PFE.N
MRK.N

U.S. FDA says 'stands ready' to work with companies developing Ebola drugs

CHICAGO, Aug 1 - The worst Ebola outbreak in history is heaping new pressure on U.S. regulators to speed the development of treatments for the deadly virus, which has killed more than 700 people since February.

U.S. CDC lab inspectors may have risked public safety -documents

WASHINGTON, Aug 1 - U.S. laboratory inspectors charged with protecting the public from the release of deadly pathogens were repeatedly criticized by a federal watchdog for overlooking biosafety lapses long before this year's anthrax scare at the Centers for Disease Control and Prevention (CDC).

9:22pm EDT

UPDATE 4-U.S. prepares to receive two American aid workers stricken with Ebola

(Adds hospital spokeswoman saying first patient expected Saturday)

9:01pm EDT

UPDATE 2-Express Scripts drops Amgen anemia drugs from formulary

Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.

UPDATE 3-U.S. prepares to receive two American aid workers stricken with Ebola

(Adds details on patient care, possible arrival on Saturday, reaction)

7:32pm EDT
Healthcare
Johnson & Johnson $99.90 -0.19%
Pfizer Inc $28.86 +0.56%
Merck & Co Inc $56.80 +0.11%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.